ConductScience.org, home

Paper27068280

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Olsson B and 14 others. Lancet Neurol, 2016. Cited by 1,591 papers, by iCite.

Cite this record

ConductScience Library. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Papers, record 27068280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27068280

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
PubMed
Journal
Lancet Neurol
PubMed
Year
2016
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
1,591
iCite
Relative citation ratio, by iCite
65.3
iCite
Revised in PubMed
2025-06-26
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Olsson BBob
2Lautner RRonald
3Andreasson UUlf
4Öhrfelt AAnnika
5Portelius EErik
6Bjerke MMaria
7Hölttä MMikko
8Rosén CChristoffer
9Olsson CCaroline
10Strobel GGabrielle
11Wu EElizabeth
12Dakin KKelly
13Petzold MMax
14Blennow KKaj
15Zetterberg HHenrik

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
BiomarkersMajor topic
Humans

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05020626Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease DiagnosisBackgroundClinicalTrials.gov
NCT05023564PUMCH Dementia Longitudinal Cohort StudyBackgroundClinicalTrials.gov
NCT05588115Rapid, Accurate, Cost-effective Assessment of Blood Biomarkers for Diagnosis of ConcussionBackgroundClinicalTrials.gov
NCT05601856Gut Microbiome and Blood Indices in Patients With AD and Their Spousal CaregiversBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in27302222Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?https://conductscience.org/library/papers/27302222PubMed
Comment in27751543The clinical value of fluid biomarkers for dementia diagnosis.https://conductscience.org/library/papers/27751543PubMed
Comment in27751544The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply.https://conductscience.org/library/papers/27751544PubMed

Download CSV of comments and corrections

Cited by1,094

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,591 citations.

PMIDTitleJournalYearIn PapersSource
42977753Vasomechanic treatment is associated with increased efflux of human brain proteins.Nat Commun2026https://conductscience.org/library/papers/42977753PubMed
42964576Plasma Biomarkers Differentiate Cognitive Impairment in Postmenopausal Women with Insomnia Disorder.Psychiatry Clin Psychopharmacol2026https://conductscience.org/library/papers/42964576PubMed
42947286CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults.Alzheimers Dement2026https://conductscience.org/library/papers/42947286PubMed
42940213Paired CSF-Plasma Analyte Signal Contrasts Across Alzheimer's Disease Clinical Stages and MCI-to-Dementia Conversion.Biomedicines2026https://conductscience.org/library/papers/42940213PubMed
42913321Multi-omics analysis of potential therapeutic targets for Alzheimer's disease and associated differences in immune cell infiltration.Neurotherapeutics2026https://conductscience.org/library/papers/42913321PubMed
42871474Global research trends and hotspots in blood-based biomarkers for Alzheimer's disease: a bibliometric analysis.Front Aging Neurosci2026https://conductscience.org/library/papers/42871474PubMed
42861666Cross-cohort NULISAseq identifies tau-anchored CSF and plasma-specific signatures across the amyloid-positive Alzheimer's disease.Alzheimers Dement2026https://conductscience.org/library/papers/42861666PubMed
42840744The role of neurofilament light chain and other fluid biomarkers in cerebellar ataxias.Brain Commun2026https://conductscience.org/library/papers/42840744PubMed
42832237Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Randomized Clinical Trial.JAMA Neurol2026https://conductscience.org/library/papers/42832237PubMed
42736978Long-Term Cognitive and Functional Outcomes of Anesthesia and Surgery in Patients with Dementia.Healthcare (Basel)2026https://conductscience.org/library/papers/42736978PubMed
42698737Translating blood-based biomarkers into Alzheimer's disease clinical practice: screening, diagnosis, and longitudinal monitoring.Front Aging Neurosci2026https://conductscience.org/library/papers/42698737PubMed
42696209Targeting cytokine-driven neuroinflammation in Alzheimer's disease: mechanistic insights and pharmacological strategies.Inflammopharmacology2026https://conductscience.org/library/papers/42696209PubMed
42677779CSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map.Brain Behav2026https://conductscience.org/library/papers/42677779PubMed
42631717Diagnostic value of blood p-tau subtypes in Alzheimer's disease progression and pathology: systematic review and meta-analysis.Eur Arch Psychiatry Clin Neurosci2026https://conductscience.org/library/papers/42631717PubMed
42626456Circulating neuron-derived cfDNA for blood-based detection of Alzheimer's and other neurodegenerative conditions.Front Neurol2026https://conductscience.org/library/papers/42626456PubMed
42624989Targeting soluble misfolded oligomers in anti-amyloid research.Nat Rev Chem2026https://conductscience.org/library/papers/42624989PubMed
42620814Language-enhanced generative modeling for amyloid PET synthesis from MRI and blood biomarkers.iScience2026https://conductscience.org/library/papers/42620814PubMed
42620101Regional Cerebrospinal Fluid Motility as a Key Determinant of Soluble Amyloid-β Levels and Kinetics.Res Sq2026https://conductscience.org/library/papers/42620101PubMed
42587260Cerebrospinal fluid/plasma albumin quotient in dementia: a systematic review of biomarker potential and clinical associations.Geroscience2026https://conductscience.org/library/papers/42587260PubMed
42581030Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India.Alzheimers Dement2026https://conductscience.org/library/papers/42581030PubMed

See all 1,094 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27068280

GET https://conductscience.org/api/papers/v1/27068280/cited_by?page=2